Total Liabilities Summary of Qiagen N.V.

Qiagen N.V.'s latest annual total liabilities in 2023 was 2.3 Billion USD , down -18.21% from previous year.
Qiagen N.V.'s latest quarterly total liabilities in 2024 Q2 was 2.17 Billion USD , down -1.22% from previous quarter.
Qiagen N.V. reported annual total liabilities of 2.82 Billion USD in 2022, down -7.52% from previous year.
Qiagen N.V. reported annual total liabilities of 3.05 Billion USD in 2021, down -12.55% from previous year.
Qiagen N.V. reported quarterly total liabilities of 2.17 Billion USD for 2024 Q2, down -1.22% from previous quarter.
Qiagen N.V. reported quarterly total liabilities of 2.3 Billion USD for 2023 FY, down -18.21% from previous quarter.

Annual Total Liabilities Chart of Qiagen N.V. (2023 - 1995)

Historical Annual Total Liabilities of Qiagen N.V. (2023 - 1995)

Year	Total Liabilities	Total Liabilities Growth
2023	2.3 Billion USD	-18.21%
2022	2.82 Billion USD	-7.52%
2021	3.05 Billion USD	-12.55%
2020	3.48 Billion USD	29.24%
2019	2.69 Billion USD	-13.31%
2018	3.11 Billion USD	24.66%
2017	2.49 Billion USD	46.82%
2016	1.7 Billion USD	4.51%
2015	1.62 Billion USD	-9.39%
2014	1.79 Billion USD	31.65%
2013	1.36 Billion USD	-2.64%
2012	1.4 Billion USD	16.93%
2011	1.19 Billion USD	-16.62%
2010	1.43 Billion USD	-4.49%
2009	1.5 Billion USD	5.16%
2008	1.43 Billion USD	3.5%
2007	1.38 Billion USD	114.14%
2006	645.84 Million USD	105.13%
2005	314.84 Million USD	0.2%
2004	314.22 Million USD	44.71%
2003	217.14 Million USD	13.4%
2002	191.48 Million USD	32.98%
2001	143.99 Million USD	119.22%
2000	65.68 Million USD	18.44%
1999	55.45 Million USD	65.04%
1998	33.6 Million USD	34.94%
1997	24.9 Million USD	34.59%
1996	18.5 Million USD	32.14%
1995	14 Million USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q1	2.2 Billion USD	-4.38%
2024 Q2	2.17 Billion USD	-1.22%
2023 FY	2.3 Billion USD	-18.21%
2023 Q3	2.21 Billion USD	-18.75%
2023 Q4	2.3 Billion USD	4.27%
2023 Q1	2.71 Billion USD	-3.66%
2023 Q2	2.72 Billion USD	0.22%
2022 Q4	2.82 Billion USD	-11.53%
2022 Q2	2.87 Billion USD	-2.48%
2022 FY	2.82 Billion USD	-7.52%
2022 Q1	2.94 Billion USD	-3.48%
2022 Q3	3.18 Billion USD	11.06%
2021 Q3	3.02 Billion USD	3.42%
2021 Q4	3.05 Billion USD	0.68%
2021 FY	3.05 Billion USD	-12.55%
2021 Q1	2.91 Billion USD	-16.49%
2021 Q2	2.92 Billion USD	0.58%
2020 Q3	3.06 Billion USD	14.46%
2020 Q4	3.48 Billion USD	13.98%
2020 Q2	2.67 Billion USD	-0.58%
2020 Q1	2.68 Billion USD	-0.36%
2020 FY	3.48 Billion USD	29.24%
2019 Q1	2.81 Billion USD	-9.61%
2019 Q2	2.75 Billion USD	-2.28%
2019 Q3	2.67 Billion USD	-2.72%
2019 Q4	2.69 Billion USD	0.89%
2019 FY	2.69 Billion USD	-13.31%
2018 Q2	2.78 Billion USD	10.31%
2018 Q1	2.52 Billion USD	1.09%
2018 FY	3.11 Billion USD	24.66%
2018 Q4	3.11 Billion USD	12.33%
2018 Q3	2.77 Billion USD	-0.48%
2017 Q4	2.49 Billion USD	-1.28%
2017 FY	2.49 Billion USD	46.82%
2017 Q3	2.52 Billion USD	23.37%
2017 Q2	2.05 Billion USD	25.2%
2017 Q1	1.63 Billion USD	-3.71%
2016 Q2	1.49 Billion USD	-0.2%
2016 FY	1.7 Billion USD	4.51%
2016 Q1	1.49 Billion USD	-8.16%
2016 Q4	1.7 Billion USD	2.33%
2016 Q3	1.66 Billion USD	11.42%
2015 FY	1.62 Billion USD	-9.39%
2015 Q1	1.69 Billion USD	-5.84%
2015 Q3	1.63 Billion USD	2.85%
2015 Q4	1.62 Billion USD	-0.7%
2015 Q2	1.59 Billion USD	-5.78%
2014 Q4	1.79 Billion USD	2.79%
2014 FY	1.79 Billion USD	31.65%
2014 Q3	1.74 Billion USD	-3.39%
2014 Q2	1.8 Billion USD	3.13%
2014 Q1	1.75 Billion USD	28.54%
2013 Q3	1.37 Billion USD	-0.15%
2013 Q4	1.36 Billion USD	-1.04%
2013 FY	1.36 Billion USD	-2.64%
2013 Q1	1.34 Billion USD	-4.2%
2013 Q2	1.38 Billion USD	2.84%
2012 Q1	1.16 Billion USD	-2.97%
2012 FY	1.4 Billion USD	16.93%
2012 Q3	1.24 Billion USD	0.77%
2012 Q4	1.4 Billion USD	12.61%
2012 Q2	1.23 Billion USD	6.2%
2011 Q1	1.42 Billion USD	-1.1%
2011 Q3	1.36 Billion USD	-2.86%
2011 Q4	1.19 Billion USD	-12.12%
2011 FY	1.19 Billion USD	-16.62%
2011 Q2	1.4 Billion USD	-1.24%
2010 Q4	1.43 Billion USD	-1.54%
2010 Q3	1.46 Billion USD	1.87%
2010 FY	1.43 Billion USD	-4.49%
2010 Q2	1.43 Billion USD	-2.44%
2010 Q1	1.46 Billion USD	-2.4%
2009 Q4	1.5 Billion USD	-1.38%
2009 Q1	1.36 Billion USD	-4.3%
2009 Q2	1.43 Billion USD	4.82%
2009 Q3	1.52 Billion USD	6.3%
2009 FY	1.5 Billion USD	5.16%
2008 Q3	1.41 Billion USD	1.5%
2008 Q4	1.43 Billion USD	1.18%
2008 FY	1.43 Billion USD	3.5%
2008 Q1	1.39 Billion USD	0.55%
2008 Q2	1.39 Billion USD	0.23%
2007 FY	1.38 Billion USD	114.14%
2007 Q3	1.36 Billion USD	112.17%
2007 Q4	1.38 Billion USD	1.15%
2007 Q1	662.17 Million USD	2.53%
2007 Q2	644.43 Million USD	-2.68%
2006 Q2	641.01 Million USD	100.79%
2006 Q4	645.84 Million USD	0.2%
2006 FY	645.84 Million USD	105.13%
2006 Q1	319.24 Million USD	1.4%
2006 Q3	644.53 Million USD	0.55%
2005 Q1	300.56 Million USD	-4.35%
2005 Q3	302.42 Million USD	-5.52%
2005 FY	314.84 Million USD	0.2%
2005 Q4	314.84 Million USD	4.11%
2005 Q2	320.08 Million USD	6.5%
2004 Q4	314.22 Million USD	8.33%
2004 FY	314.22 Million USD	44.71%
2004 Q2	218.05 Million USD	3.48%
2004 Q3	290.07 Million USD	33.03%
2004 Q1	210.73 Million USD	-2.95%
2003 Q1	201.1 Million USD	5.03%
2003 FY	217.14 Million USD	13.4%
2003 Q3	198.91 Million USD	2.85%
2003 Q4	217.14 Million USD	9.16%
2003 Q2	193.4 Million USD	-3.83%
2002 FY	191.48 Million USD	32.98%
2002 Q2	172.68 Million USD	19.5%
2002 Q1	144.5 Million USD	0.36%
2002 Q3	175.71 Million USD	1.75%
2002 Q4	191.48 Million USD	8.97%
2001 Q4	143.99 Million USD	57.41%
2001 Q3	91.47 Million USD	4.8%
2001 Q2	87.28 Million USD	11.58%
2001 Q1	78.22 Million USD	19.09%
2001 FY	143.99 Million USD	119.22%
2000 Q3	59.22 Million USD	-10.04%
2000 Q1	46.14 Million USD	-16.79%
2000 FY	65.68 Million USD	18.44%
2000 Q4	65.68 Million USD	10.9%
2000 Q2	65.83 Million USD	42.67%
1999 Q2	45.3 Million USD	-3.21%
1999 Q3	44.85 Million USD	-0.97%
1999 Q4	55.45 Million USD	23.62%
1999 FY	55.45 Million USD	65.04%
1999 Q1	46.8 Million USD	39.29%
1998 Q4	33.6 Million USD	0.9%
1998 Q3	33.3 Million USD	21.98%
1998 Q1	26.8 Million USD	7.63%
1998 FY	33.6 Million USD	34.94%
1998 Q2	27.3 Million USD	1.87%
1997 Q1	22.3 Million USD	20.54%
1997 Q2	21.8 Million USD	-2.24%
1997 FY	24.9 Million USD	34.59%
1997 Q3	23.5 Million USD	7.8%
1997 Q4	24.9 Million USD	5.96%
1996 FY	18.5 Million USD	32.14%
1996 Q4	18.5 Million USD	0.0%
1996 Q1	14.3 Million USD	0.0%
1995 FY	14 Million USD	0.0%

Peer Total Liabilities Comparison of Qiagen N.V.

Name	Total Liabilities	Total Liabilities Difference
Agilent Technologies, Inc.	4.91 Billion USD	53.082%
Charles River Laboratories International, Inc.	4.53 Billion USD	49.131%
Quest Diagnostics Incorporated	7.6 Billion USD	69.655%
Danaher Corporation	30.99 Billion USD	92.556%
Enzo Biochem, Inc.	29.65 Million USD	-7681.688%
IQVIA Holdings Inc.	20.56 Billion USD	88.782%
Laboratory Corporation of America Holdings	8.83 Billion USD	73.882%
Mettler-Toledo International Inc.	3.5 Billion USD	34.177%
Revvity, Inc.	5.69 Billion USD	59.461%
Thermo Fisher Scientific Inc.	51.88 Billion USD	95.553%
Waters Corporation	3.47 Billion USD	33.628%

Global Stocks Search

Qiagen N.V. (QGEN)

Total Liabilities Summary of Qiagen N.V.

Annual Total Liabilities Chart of Qiagen N.V. (2023 - 1995)

Historical Annual Total Liabilities of Qiagen N.V. (2023 - 1995)

Peer Total Liabilities Comparison of Qiagen N.V.